Company: ARAI
Filing Date: 2025-01-27
Form Type: S-1/A
Source: 0001493152-25-003660
Chunk: 201

Company: Arrive AI Inc.
Filing Date: 2025-01-27
Form: S-1/A
Chunk 201
---
 |

The following is a summary of the changes in nonvested share options (on a post-reverse split basis) as of September 30, 2024:

|                    |     | Share   
 Options |         |   |     | Weighted              
 Average               
 Grant Date Fair Value |       |
|:-------------------|:----|:--------|--------:|:--|:----|:----------------------|------:|
| NONVESTED          
 SHARE OPTIONS -    
 DECEMBER 31, 2023  |     |         | 494,105 |   |     | $                     | 10.80 |
| Granted            |     |         |  45,563 |   |     |                       | 11.80 |
| Vested             |     |         | (64,161 | ) |     |                       | 10.88 |
| Cancelled          |     |         |    (130 | ) |     |                       | 10.32 |
| NONVESTED          
 SHARE OPTIONS -    
 SEPTEMBER 30, 2024 |     |         | 475,377 |   |     | $                     | 10.88 |

| F-54 |

<div align='center'>ARRIVE TECHNOLOGY INC.

(FORMERLY DRONEDEK CORPORATION)

NOTES TO FINANCIAL STATEMENTS (Continued)</div>

| 13. | EQUITY                     
 INCENTIVE PLAN (Continued) |

There were 45,563 options (on a post-reverse split basis) granted during the nine months ended September 30, 2024 and each option had an average grant date fair value of $11.80 per share (as adjusted for the 1-for-4 reverse split). As of September 30, 2024, there was $5,176,599 unrecognized compensation expense related to nonvested stock options to be recognized over the remaining vesting period. Total compensation expense during the nine months ended September 30, 2024 was $732,293. No options were exercised during the nine months ended September 30, 2024.

| 14. | RESEARCH                
 AND DEVELOPMENT CREDITS |

Under the Internal Revenue Service (IRS) Form 6765, the Company is eligible to claim a credit related to research and development expenses. The research credit is generally allowed for expenses paid or incurred for qualified research. Qualified research means research for which expenses may be treated as section 174 expenses. This research